Entity: all
News about Biogen
ShareAnalyse the news about Biogen from multiple sources, get visualizations or extract the entire dataset.
Related dashboards:
- Biogen (organization)
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Ozempic hits booze sales, Moderna likes AI, and Biogen's blockbuster drug: Pharma news roundup
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Stocks making the biggest moves midday: JetBlue Airways, Shopify, Biogen and more
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Biogen dumps dubious Alzheimer's drug after profit-killing FDA scandal
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Biogen to shut down its controversial Alzheimer's drug Aduhelm
Dataset
Extract all news on this scope:
Analysis
See the trend on this scope:
Evolution through time
Sources analysis:
Distribution of sources in the news
Sections analysis:
Distribution of sections in the news
Current sentiment polarity: neutral with a score of 0.06
| neutral | 42% | |
| positive | 32% | |
| negative | 26% |
Sentiment polarity through time
